How Cooper was paid
$5.8M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Bonus | Options | Incentive | Other | Total |
|---|---|---|---|---|---|---|
| Ronald H.W. CooperChief Executive Officer and President | $700,000 | — | $4,544,760 | $483,000 | $30,529 | $5,758,289 |
| Ryan DawsChief Financial Officer | $473,000 | — | $1,497,097 | $222,640 | $23,389 | $2,216,126 |
| Hussein SweitiChief Medical Officer | $43,750 | $212,195 | $2,894,340 | — | $1,617 | $3,151,902 |
What changed and why
- $5.8M$5,758,289 was CEO total compensation in 2025, compared with $8,433,812 in 2024.
- $4.5M$4,544,760 was the CEO’s 2025 option award value.
- $212K$212,195 was Dr. Sweiti’s bonus, including sign-on, one-time, and discretionary payments.
- $483K$483,000 was the CEO’s non-equity incentive compensation based on corporate performance goals.
- Clinical development, manufacturing, regulatory preparation, financial discipline, and awareness were 2025 performance areas.
- 600,000 stock options were awarded to Dr. Sweiti upon joining in September 2025.
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.